Penry Price joins Mawdsleys
Penry Price joins Mawdsleys 21st February 2015

Mawdsleys is delighted to welcome Penry Price to the company to head up the generic purchasing division (February 2015).

 

Penry, who joins Mawdsleys from Alliance Healthcare, has been appointed to work alongside Gary Winkle, the new Purchasing Director.

 

Penry has many plans for the generic portfolio at Mawdsleys which all involve continuing to develop the generic proposition.

 

Penry says “It’s great to now be heading up the generic portfolio at Mawdsleys.  I am looking forward to putting my plans into place and ensuring Mawdsleys remains the competitive player in the market that it is.”

 

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-helps-client-deliver-major-project-to-large-chain-of-opticians/ thumbnail image Mawdsleys helps client deliver major project to large chain of opticians

We’re delighted with the feedback that our over-labelling and MPW (Mawdsleys Pre Wholesale) teams received from Thea Pharmaceuticals when they delivered on a major project for a large chain of opticians, despite the goal posts shifting a few times.   Thea, a client of Mawdsleys 3PL division, MPW, needed Mawdsleys…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-oncoscience-launch-a-named-patient-program-for-cimaher-nimotuzumab-in-the-uk-and-ireland/ thumbnail image Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…

Read more
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.